Literature DB >> 19043822

JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy.

Serena Delbue1, Emanuela Branchetti, Simone Bertolacci, Eleonora Tavazzi, Enrico Marchioni, Renato Maserati, Giulia Minnucci, Sara Tremolada, GianLuca Vago, Pasquale Ferrante.   

Abstract

JC virus (JCV) is a human polyomavirus that causes progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease that mainly affects immunocompromised subjects. Since its discovery, PML has been considered a rapidly progressing fatal disease; however, amino acid substitutions in the capsid viral protein have recently been tentatively associated with changes in PML clinical course. In order to provide more insight to PML pathogenesis and identify potential prognostic markers, seven cerebrospinal fluid (CSF) samples and four brain autopsy samples were collected from patients afflicted with PML with different clinical courses (fast- and slow-progressing), and the JCV VP1 coding region was amplified, cloned, and sequenced. In addition, urine samples were collected and analyzed from nine patients with PML or other neurological diseases (ONDs) as a control group. Sequencing analysis of the genomic region encoding the VP1 outer loops revealed polymorphic residues restricted to four positions (74, 75, 117, and 128) in patients with slow PML progression, whereas no significant mutation was found in JCV isolated from urine. Collectively, these data show that JCV VP1 loop mutations are associated with a favorable prognosis for PML. It is therefore possible that slower progression of PML may be related to the emergence of a less virulent JCV strain with a lower replication rate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19043822      PMCID: PMC2678919          DOI: 10.1080/13550280802425467

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  22 in total

1.  Structure of simian virus 40 at 3.8-A resolution.

Authors:  R C Liddington; Y Yan; J Moulai; R Sahli; T L Benjamin; S C Harrison
Journal:  Nature       Date:  1991-11-28       Impact factor: 49.962

2.  Progressive multifocal leukoencephalopathy.

Authors:  B R Brooks; D L Walker
Journal:  Neurol Clin       Date:  1984-05       Impact factor: 3.806

3.  Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).

Authors:  Andrea Antinori; Antonella Cingolani; Patrizia Lorenzini; Maria Letizia Giancola; Ilaria Uccella; Simona Bossolasco; Susanna Grisetti; Francesca Moretti; Beniamino Vigo; Marco Bongiovanni; Bruno Del Grosso; Maria Irene Arcidiacono; Giovanni Carlo Fibbia; Maurizio Mena; Maria Grazia Finazzi; Giovanni Guaraldi; Adriana Ammassari; Antonella d'Arminio Monforte; Paola Cinque; Andrea De Luca
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

4.  Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals.

Authors:  Y Yogo; T Kitamura; C Sugimoto; T Ueki; Y Aso; K Hara; F Taguchi
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

5.  Human polyomavirus JC virus genome.

Authors:  R J Frisque; G L Bream; M T Cannella
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

6.  Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure.

Authors:  G S Ault; G L Stoner
Journal:  J Gen Virol       Date:  1993-08       Impact factor: 3.891

Review 7.  Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases.

Authors:  J R Berger; B Kaszovitz; M J Post; G Dickinson
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

8.  DNA rearrangements in organ-specific variants of polyomavirus JC strain GS.

Authors:  G Loeber; K Dörries
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

9.  Identification of amino acid residues in BK virus VP1 that are critical for viability and growth.

Authors:  Aisling S Dugan; Megan L Gasparovic; Natia Tsomaia; Dale F Mierke; Bethany A O'Hara; Kate Manley; Walter J Atwood
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

10.  High fidelity DNA synthesis by the Thermus aquaticus DNA polymerase.

Authors:  K A Eckert; T A Kunkel
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

View more
  16 in total

1.  A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy.

Authors:  Nobuo Sanjo; Yurie Nose; Yukiko Shishido-Hara; Saneyuki Mizutani; Yoshiki Sekijima; Hitoshi Aizawa; Toru Tanizawa; Takanori Yokota
Journal:  J Neurol       Date:  2018-12-03       Impact factor: 4.849

Review 2.  Progressive multifocal leukoencephalopathy: clinical and molecular aspects.

Authors:  Eleonora Tavazzi; Martyn K White; Kamel Khalili
Journal:  Rev Med Virol       Date:  2011-09-21       Impact factor: 6.989

Review 3.  Structural evaluation of new human polyomaviruses provides clues to pathobiology.

Authors:  Edward M Johnson
Journal:  Trends Microbiol       Date:  2010-02-20       Impact factor: 17.079

4.  VP-1 quasispecies in human infection with polyomavirus BK.

Authors:  Chunqing Luo; Hans H Hirsch; Jeffrey Kant; Parmjeet Randhawa
Journal:  J Med Virol       Date:  2011-11-03       Impact factor: 2.327

5.  Susceptibility of Primary Human Choroid Plexus Epithelial Cells and Meningeal Cells to Infection by JC Virus.

Authors:  Bethany A O'Hara; Gretchen V Gee; Walter J Atwood; Sheila A Haley
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

6.  Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option.

Authors:  P Ripellino; C Comi; M Mula; C Varrasi; A Conconi; A Stecco; D Brustia; N Nasuelli; K Savio; L De Paoli; R Cantello; G Gaidano; F Monaco
Journal:  BMJ Case Rep       Date:  2011-04-15

7.  Analysis of variability of urinary excreted JC virus strains in patients infected with HIV and healthy donors.

Authors:  Danijela Karalic; Ivana Lazarevic; Ana Banko; Maja Cupic; Djordje Jevtovic; Tanja Jovanovic
Journal:  J Neurovirol       Date:  2017-12-14       Impact factor: 2.643

8.  JC Polyomavirus Attachment and Entry: Potential Sites for PML Therapeutics.

Authors:  Colleen L Mayberry; Christian D S Nelson; Melissa S Maginnis
Journal:  Curr Clin Microbiol Rep       Date:  2017-08-01

Review 9.  JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection.

Authors:  Melissa S Maginnis; Christian D S Nelson; Walter J Atwood
Journal:  J Neurovirol       Date:  2014-07-31       Impact factor: 2.643

10.  Association between the JC polyomavirus infection and male infertility.

Authors:  Manola Comar; Nunzia Zanotta; Eleonora Croci; Immacolata Murru; Roberto Marci; Cecilia Pancaldi; Ornella Dolcet; Stefania Luppi; Monica Martinelli; Elena Giolo; Giuseppe Ricci; Mauro Tognon
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.